Abre
Payments companies reported to CMS as associated with Abre. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Abre, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Abre
These are the largest totals companies reported as associated with Abre. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Erin Murphy | Charlotte, NC | Vascular Surgery | $114,258.12 |
| David Stewart | Chicago, IL | Interventional Cardiology | $68,635.09 |
| Kush Desai | Chicago, IL | Vascular & Interventional Radiology | $45,441.58 |
| Vamsi Krishna | Kyle, TX | Interventional Cardiology | $40,004.53 |
| Anas Safadi | Hobart, IN | Cardiovascular Disease | $37,639.85 |
| Robert Mendes | Raleigh, NC | Vascular Surgery | $34,283.41 |
| Gloria Salazar | Chapel Hill, NC | Vascular & Interventional Radiology | $22,476.54 |
| Paul Gagne | Darien, CT | Vascular Surgery | $20,651.97 |
| Micah Girotti | Bel Air, MD | Vascular Surgery | $19,222.85 |
| Wail Asfour | Munster, IN | Cardiovascular Disease | $18,465.04 |
Prescribed Abre?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.